Renal Cell Carcinoma (Record no. 25060)

MARC details
000 -LEADER
fixed length control field 02846nam a2200121Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220620s9999||||xx |||||||||||||| ||und||
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name López, José I.
245 #0 - TITLE STATEMENT
Title Renal Cell Carcinoma
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element N-glycomapping||n/a||SMAD proteins||patient survival||pro-IL-1?||survival prediction||inflammation markers||tumor migration||prognostic factors||practical approach||circular RNAs in a clinico-genomic predictive model||glycomarkers||review||nephrectomy||uric acid||VEGF inhibitors||metabolic reprogramming||collecting duct carcinoma||curcumin||metabolome profiling||identification of circular RNAs||IL-2||experimental validation of circular RNA||Raf/MEK/ERK||HOT||PI3K/Akt/mTOR||pentose phosphate pathway||kidney cancer||LOT||mutation||RCC||polybromo-1||pale cell||MMP-9||gene expression||recurrence free survival||chromosomal loss||IL-1?||chronic kidney disease||glutathione transferase omega 2||label-free||glutathione transferase omega 1||emerging entity||copy number alteration||FOXO3||predictive role||tumor slice culture||tyrosine kinase inhibitors||PPP||ESC||CDKN1A expression||metastasis||PD-L1||diagnostic and prognostic markers||EVI1||copy number loss||RNA sequencing||NK cells||glutathione metabolism||clear cell renal cell carcinoma||renal cell cancer||proliferation||eosinophilic variant||Xp11 translocation renal cell carcinoma||prognosis||invasion||immune infiltration||IL4R?||FISH||11) translocation renal cell carcinoma||tumor microenvironment||metabolome||hyperosmolality||toxicity||ALK||drug sensitivity||t(6||copy number analysis||urine||genetic association||polymorphism||solute carrier proteins||kidney||metastatic ccRCC||molecular genetic features||recurrence-free survival||chromophobe renal cell carcinoma||unclassified renal tumor||overall survival||mTOR inhibitors||mTOR||JAK2||von Hippel–Lindau||miR-155-5p||glycoproteomics||PBRM1||miR-133b||survival||TFE3||TFEB||oncocytic renal tumor||immune checkpoint inhibitors||biomarker||MMP10||TCGA||ghrelin||EMT like||checkpoint inhibitors||MiT family translocation renal cell carcinoma||gene signature||sarcomatoid||transforming growth factor beta||clear cell Renal Cell Carcinoma||tumor adhesion||renal cancer||unclassified renal cell carcinoma||Papillary renal cell carcinoma (pRCC)||miR-146a-5p||renal cell||everolimus||integrins||cytoreductive nephrectomy||immunotherapy||predictive factors||immunohistochemistry||MTA2||IL13R?1||targeted therapy||intratumour heterogeneity||aurora A||TCA cycle||AMP-activated protein kinases||cancer-specific survival||programmed death-ligand 1||efficacy||renal cell carcinoma||anaplastic lymphoma kinase rearrangement||TFEB-amplified renal cell carcinoma||statins||cancer immunotherapy||microRNA||new entity||proteome profiling
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/2229">https://mdpi.com/books/pdfview/book/2229</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 20/06/2022   20/06/2022 20/06/2022 E-Books